MATRX Pharmaceuticals S A : SEC Investor Advisory Committee Discusses SPACs	16.03.21
An unknown buyer acquired 58% stake in MATRX Pharmaceuticals S.A. from Ajay Pal.	28.12.18
An unknown buyer acquired 65% stake in MATRX Pharmaceuticals S.A. from PRO SP. Z O.O.	25.06.18
PRO SP. Z O.O. acquired 65% stake in MATRX Pharmaceuticals S.A..	06.03.18
CoGyn Pharmaceuticals, Inc. completed the acquisition of MATRX Pharmaceuticals S.A. in a reverse merger transaction.	11.03.16

Manager	Titel	Alter	Seit
Ajay Pal CEO	Chief Executive Officer	-	08.06.18
Robert S. Cohen CEO	Chief Executive Officer	-	15.12.08
Charles M. Mixon DFI	Director of Finance/CFO	-	-

Aufsichtsräte	Titel	Alter	Seit
Dominik Zbigniew Dymecki BRD	Director/Board Member	43	21.06.17
Edyta Jeleniewska BRD	Director/Board Member	53	21.06.17
Malgorzata Dymecka BRD	Director/Board Member	45	21.06.17

Unternehmensprofil

Sektor